Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ipratropium bromide 20micrograms/dose inhaler CFC free
0301020I0AAANAN
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | 38,237 |
|
Easyhaler Beclometasone 200micrograms/dose dry pdr inhaler
0302000C0BNAABU
|
Easyhaler (Beclometasone) | Beclometasone dipropionate | Respiratory System | 37,989 |
|
Chlorphenamine 2mg/5ml oral solution sugar free
0304010G0AAAPAP
|
Chlorphenamine maleate | Chlorphenamine maleate | Respiratory System | 34,832 |
|
Spiolto Respimat 2.5microg/dose / 2.5microg/dose soln refill
0301040X0BBABAB
|
Spiolto Respimat | Tiotropium bromide/olodaterol | Respiratory System | 34,277 |
|
Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials
0301011R0AABDBD
|
Salbutamol | Salbutamol | Respiratory System | 31,940 |
|
Beclometasone 100micrograms/dose inhaler CFC free
0302000C0AABFBF
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 31,794 |
|
Sereflo 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BIABBG
|
Sereflo | Fluticasone propionate (Inhalation) | Respiratory System | 31,375 |
|
Loratadine 5mg/5ml oral solution
0304010D0AAABAB
|
Loratadine | Loratadine | Respiratory System | 30,051 |
|
Sereflo 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BIAABF
|
Sereflo | Fluticasone propionate (Inhalation) | Respiratory System | 29,844 |
|
NACSYS 600mg effervescent tablets
0307000C0BNAAAR
|
NACSYS | Acetylcysteine | Respiratory System | 29,659 |
|
Carbocisteine 250mg/5ml oral solution
0307000J0AAACAC
|
Carbocisteine | Carbocisteine | Respiratory System | 29,560 |
|
Acetylcysteine 600mg effervescent tablets sugar free
0307000C0AAARAR
|
Acetylcysteine (Mucolytic) | Acetylcysteine | Respiratory System | 29,016 |
|
Budesonide 200mcg/dose / Formoterol 6mcg/dose dry powder inh
0302000K0AAAMAM
|
Budesonide (Inhalation) | Budesonide | Respiratory System | 28,707 |
|
Salmeterol 25micrograms/dose inhaler CFC free
0301011U0AAAHAH
|
Salmeterol | Salmeterol | Respiratory System | 28,265 |
|
Pulmicort 200 Turbohaler
0302000K0BBAHAG
|
Pulmicort | Budesonide | Respiratory System | 28,044 |
|
Symbicort 200microg/dose / 6microg/dose pressurised inh
0302000K0BDADBB
|
Symbicort | Budesonide | Respiratory System | 26,738 |
|
Fexofenadine 30mg tablets
0304010E0AAACAC
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 26,614 |
|
Qvar 100micrograms/dose Easi-Breathe inhaler
0302000C0BJAFBH
|
Qvar | Beclometasone dipropionate | Respiratory System | 26,573 |
|
Uniphyllin 300mg prolonged-release tablets
0301030S0BKACAP
|
Uniphyllin | Theophylline | Respiratory System | 25,155 |
|
Hydroxyzine 10mg tablets
0304010J0AAABAB
|
Hydroxyzine hydrochloride | Hydroxyzine hydrochloride | Respiratory System | 24,407 |
|
Montelukast 4mg granules sachets sugar free
0303020G0AAADAD
|
Montelukast | Montelukast | Respiratory System | 24,354 |
|
Easyhaler Salbutamol sulfate 200micrograms/dose dry pdr inh
0301011R0BWABAQ
|
Easyhaler (Salbutamol sulfate) | Salbutamol | Respiratory System | 24,139 |
|
Kelhale 100micrograms/dose inhaler
0302000C0BSABBF
|
Kelhale | Beclometasone dipropionate | Respiratory System | 24,075 |
|
Easyhaler Budesonide 100micrograms/dose dry powder inhaler
0302000K0BGAAAK
|
Easyhaler (Budesonide) | Budesonide | Respiratory System | 23,852 |
|
Fluticasone 125mcg/dose / Salmeterol 25mcg/dose inh CFC free
0302000N0AABFBF
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 23,802 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.